Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
16.30
+0.43 (2.71%)
At close: Mar 9, 2026, 4:00 PM EDT
16.30
0.00 (0.00%)
After-hours: Mar 9, 2026, 7:00 PM EDT
HQL Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Cash & Equivalents | 0.08 | 0 | 0 | 0 | - | |
| Cash & Short-Term Investments | 0.08 | 0 | 0 | 0 | - | |
| Cash Growth | 7553700.00% | -99.78% | -55.05% | - | - | |
| Accounts Receivable | 1.14 | 0.23 | 0.62 | 0.15 | 0.17 | |
| Other Receivables | 0.01 | 0.01 | - | - | - | |
| Receivables | 1.15 | 0.24 | 0.62 | 0.15 | 0.17 | |
| Prepaid Expenses | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | |
| Other Current Assets | - | - | 11.09 | 8.47 | 4.97 | |
| Total Current Assets | 1.26 | 0.28 | 11.74 | 8.64 | 5.16 | |
| Long-Term Investments | 465.24 | 446.4 | 391.52 | 481.17 | 419.36 | |
| Other Long-Term Assets | 48.88 | 13.9 | 11.47 | 44.37 | 59.64 | |
| Accounts Payable | 0.72 | 0 | 5.1 | - | - | |
| Accrued Expenses | 0.57 | 0.84 | 0.63 | 0.7 | 0.57 | |
| Short-Term Debt | - | - | 11.09 | 10.04 | 0.01 | |
| Other Current Liabilities | 0.43 | 0.05 | - | - | - | |
| Total Current Liabilities | 1.73 | 0.89 | 16.82 | 10.75 | 0.58 | |
| Other Long-Term Liabilities | - | - | - | - | 0.01 | |
| Common Stock | 0.3 | 0.28 | 0.26 | 0.25 | 0.24 | |
| Additional Paid-In Capital | 435.76 | 415.29 | 388.1 | 372.49 | 356.3 | |
| Retained Earnings | 77.6 | 44.13 | 9.55 | 150.7 | 127.03 | |
| Total Liabilities & Equity | 515.38 | 460.58 | 414.73 | 534.19 | 484.17 | |
| Total Debt | - | - | 11.09 | 10.04 | 0.01 | |
| Net Cash (Debt) | 0.08 | 0 | -11.09 | -10.04 | -0.01 | |
| Net Cash Growth | 7553700.00% | - | - | - | - | |
| Net Cash Per Share | 0.00 | - | -0.43 | -0.41 | -0.00 | |
| Filing Date Shares Outstanding | 29.6 | 28.06 | 25.68 | 24.67 | 23.88 | |
| Total Common Shares Outstanding | 29.6 | 28.06 | 25.68 | 24.67 | 23.88 | |
| Working Capital | -0.46 | -0.61 | -5.08 | -2.1 | 4.58 | |
| Book Value Per Share | 17.35 | 16.38 | 15.49 | 21.22 | 20.25 | |
| Tangible Book Value | 513.66 | 459.69 | 397.9 | 523.44 | 483.57 | |
| Tangible Book Value Per Share | 17.35 | 16.38 | 15.49 | 21.22 | 20.25 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.